All contributors
Onconephrology contributor
Rosner, Mitchell H
Primarily Onco-nephrology (general)#31 of 46 recognized
- #3 in Onco-nephrology (general)
26
Clinical papers
984
Citations (iCite)
8 / 9
First / senior author
2006–2026
Active years
Output over time
Clinical corpus papers per year — peak 4 in 2018, 2024.
- 2006: 1 paper
- 2012: 2 papers
- 2014: 1 paper
- 2016: 2 papers
- 2017: 3 papers
- 2018: 4 papers
- 2019: 2 papers
- 2020: 1 paper
- 2021: 2 papers
- 2022: 2 papers
- 2024: 4 papers
- 2026: 2 papers
20062026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Onco-nephrology (general)15
Anticancer drug nephrotoxicity13
Myeloma cast nephropathy5
Cellular therapy renal effects2
Tumor lysis & electrolytes2
Checkpoint-inhibitor kidney injury1
MGRS & paraprotein kidney disease1
Frequent co-authors
Other recognized contributors who most often share corpus papers with Rosner (shared-paper count).
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,541-article corpus (regenerated 2026-10-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.